CFF Industry Award for Path to a Cure (PTAC)
Supports United States biotechnology and synthetic biology teams connecting startups and industry through commercialization programs.
The Cystic Fibrosis Foundation's Industry Award for Path to a Cure (PTAC) is a venture-philanthropy funding mechanism that supports biopharmaceutical companies developing treatments aimed at the underlying cause of cystic fibrosis, specifically therapies addressing CFTR gene function, repair, or replacement. The Foundation committed an initial $500 million through 2025 under the Path to a Cure ini…
Discovery, platform development for gene delivery/editing, preclinical and/or clinical development of treatments addressing the underlying cause of CF (CFTR). Both US and international companies eligible.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
Write proposalGrant Letter of Intent: How to Write an LOI or Letter of Inquiry
Learn what a grant letter of intent is, when funders ask for LOIs or letters of inquiry, what to include, what to avoid, and how funder rules differ.
More from CFF
All grants from this funder →CFF/NIH R01 Unfunded Award
🇺🇸CFF · United States
Invests research teams and institutions for CFF NIH Unfunded Award in biotechnology and medical technology.
CFF Clinical Pilot and Feasibility Award
🇺🇸CFF · United States
Provides clinicians and translational researchers for CFF Clinical Pilot and Feasibility Award in biotechnology and medical technology.
CFF Clinical Research Award
🇺🇸CFF · United States
Supports investigator-driven clinical studies addressing diagnosis, treatment, and prevention across key medical priorities.
CFF Mission Ventures Industry Investment
🇺🇸CFF · United States
Offers startup and industry teams with commercialization support for CFF Mission Ventures Industry Investment in biotechnology, medical technology, and synthetic biology.
CFF Pilot and Feasibility Award
🇺🇸CFF · United States
Backs research teams and institutions for CFF Pilot and Feasibility Award in biotechnology and medical technology.
CFF Screening Improvement Program (SIP)
🇺🇸CFF · United States
Supports screening programmes that improve study quality, trial efficiency, and treatment progress in care pathways.
Similar grants
Browse the directory →
NIMHD SBIR Phase IIB Strategic Breakthrough Award
🇺🇸NIMHD · United States
Funds prior NIH SBIR and STTR Phase II small businesses bridging later-stage R&D to commercialization.
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
NIAID Investigator-Initiated P01
🇺🇸NIAID · United States
Supports investigator-led infectious disease and immunology multi-project teams under NIAID.
NSF SBIR/STTR Fast-Track Pilot
🇺🇸NSF · United States
Supports United States deep-tech startups through a combined early and continuation development route.
NSF SBIR Phase I
🇺🇸NSF · United States
Funds United States deep-tech startups demonstrating scientific feasibility of novel science and engineering innovations.